Tenax Therapeutics Income Statement (2010-2017) | TENX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jul2010 Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Jan2012 Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jul2014 Oct2014 Jan2015 Apr2015 Dec2015 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017
Revenue & cost
Revenue -0.00M0.01M0.03M0.04M0.02M0.10M0.15M0.10M0.27M0.51M0.22M1.67M-0.00M0.00M
Cost of Revenue 0.00M0.01M0.03M0.18M0.03M0.01M0.00M0.00M0.01M0.01M0.00M0.35M
Gross Profit 0.01M0.03M0.03M0.04M0.02M0.02M0.00M0.01M0.01M0.01M0.00M0.21M
Operating items
Research & Development 1.15M0.57M0.50M0.47M0.65M0.49M0.60M0.72M0.64M0.60M0.37M24.53M2.42M3.94M3.23M6.65M
Selling, General & Administrative 1.88M1.51M2.28M2.00M1.80M1.66M1.42M1.21M1.26M0.42M1.44M50.59M2.73M1.76M1.27M2.31M
Restructuring Costs 0.05M0.17M0.00M
Other Operating Expenses 0.30M0.03M0.61M1.03M33.27M
Operating Expenses 3.03M2.08M2.78M2.77M2.45M2.15M2.02M1.96M1.95M1.20M1.81M75.73M6.19M5.71M4.50M42.23M
Operating Income 3.02M2.06M2.75M2.73M-2.43M-2.05M-1.87M-1.86M-1.68M-0.68M-1.59M-74.06M-12.10M-5.71M-4.50M-42.23M
EBIT 3.02M2.06M2.75M2.73M-2.43M-2.05M-1.87M-1.86M-1.68M-0.68M-1.59M-74.06M-12.10M-5.71M-4.50M-42.23M
Non-operating items
Non Operating Investment Income -0.14M0.04M-0.27M
Other Non Operating Income -0.02M-0.01M-0.25M8.00-0.01M-0.00M-0.08M0.01M0.01M-0.01M323.001.23M1.29M0.34M0.23M0.41M
Non Operating Income -0.02M-0.01M-0.25M8.00-0.01M-0.00M-0.08M0.01M0.01M-0.01M323.001.23M1.29M0.34M0.23M0.41M
Net income details
EBT 3.02M2.05M2.80M2.85M-2.86M-2.93M-7.22M-2.63M-3.60M-1.55M-2.41M-118.02M-12.10M-5.71M-4.50M-42.22M
Tax Provisions -7.96M
Profit After Tax 3.00M2.05M2.54M2.85M-2.87M-2.93M-7.30M-2.61M-3.59M-1.56M-2.41M-117.04M-22.30M-12.10M-5.36M-4.27M-33.86M
Income from Continuing Operations 3.02M2.05M2.80M2.85M-2.86M-2.93M-7.22M-2.63M-3.60M-1.55M-2.41M-118.02M-12.10M-5.71M-4.50M-34.26M
Consolidated Net Income 3.02M2.05M2.80M2.85M-2.86M-2.93M-7.22M-2.63M-3.60M-1.55M-2.41M-118.02M-12.10M-5.71M-4.50M-34.26M
Income towards Parent Company 3.02M2.05M2.80M2.85M-2.86M-2.93M-7.22M-2.63M-3.60M-1.55M-2.41M-118.02M-12.10M-5.71M-4.50M-34.26M
Preferred Dividend Payments 0.96M
Net Income towards Common Stockholders 3.02M2.05M2.80M2.85M-2.86M-2.93M-7.22M-2.63M-3.60M-1.55M-2.41M118.00M-12.10M-5.71M-4.50M33.86M
Additional items
EPS (Basic) -0.13-0.09-0.11-0.12-0.12-0.12-0.26-11.59-0.12-0.05-0.07-6.05-0.21-0.01M-0.19-0.15-1.20
EPS (Weighted Average and Diluted) -0.13-0.09-0.11-0.12-0.33-0.29-0.39-13.42-0.22-0.13-0.14-6.38
Shares Outstanding (Weighted Average) 36.0036.0036.0037.0037.0043.0045.0045.0048.0051.0052.0066.00879.00879.00879.00879.00879.00882.00882.00
Shares Outstanding (Diluted Average) 23.22M23.39M23.39M23.35M24.14M25.98M29.73M1.39M1.62M1.71M1.77M1.76M2.21M4.95M10.27M9.36M27.66M28.11M28.12M
EBITDA 3.02M2.06M2.75M2.73M-2.43M-2.05M-1.87M-1.86M-1.68M-0.68M-1.59M-74.06M5.68M-12.10M5.22M4.31M33.59M
Interest Expenses 0.00M0.01M-0.04M-0.12M0.44M0.87M5.34M0.76M1.93M0.87M0.82M43.96M0.00M-0.00M
Tax Rate 18.86%